Key result
Endomyocardial biopsy remains valuable for diagnosing myocarditis and cardiomyopathies as emerging molecular technologies improve accuracy.
Endomyocardial biopsy remains a valuable diagnostic tool for specific cardiomyopathies and myocarditis, with emerging molecular techniques offering the potential to further enhance its diagnostic accuracy.
Endomyocardial biopsy supports targeted diagnostics in myocarditis and cardiomyopathies; leaves open molecular enhancements pending prospective validation.
Endomyocardial biopsy (EMB) is useful for the diagnosis of myocarditis, cardiac sarcoidosis, and non-ischemic cardiomyopathy. In this mini-review, we discuss the diagnostic potential of EMB in cases of acute/chronic-active myocarditis, sarcoidosis, idiopathic dilated cardiomyopathy and arrhythmogenic right ventricular dysplasia. We also summarize the complications caused by endomyocardial biopsy procedures. Importantly, we finally review the emerging molecular biology technologies as well as biological engineering techniques that can help improve the diagnostic accuracy of EMB to diagnose myocarditis and cardiomyopathies, promoting the management of these diseases.
No takes yet. Share an insight, caveat, or question.
Li et al. (2018) conducted a review in Acute myocarditis, idiopathic dilated cardiomyopathy, and arrhythmogenic right ventricular dysplasia. Endomyocardial biopsy (EMB) was evaluated. Endomyocardial biopsy serves as a valuable diagnostic tool for myocarditis and cardiomyopathies, with emerging molecular technologies poised to further enhance its diagnostic accuracy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: